US Patent 11667687 Masked activatable interferon constructs
Patent 11667687 was granted and assigned to CytomX Therapeutics on June, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11667687 Masked activatable interferon constructs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.